FAS and metabolic dysfunction-associated steatotic liver disease: Further to these measurements of the products of DNL in NAFLD, quantification of transcriptional data for SREBP1c, FAS and ACC1 shows elevation in these crucial regulators and enzymes of DNL in patients with NAFLD (Higuchi et al., 2008).